12.5907.49% ( -1.020 )
Closed: Nov 13, 16:00:00 (EDT)Profile
About

Aspen Neuroscience
ASPE.US
Aspen Neuroscience, Inc. develops autologous induced pluripotent stem cell (iPSC)-derived cell replacement therapies for neurodegenerative diseases. The company's develops ANPD001, an investigational single-dose, autologous dopaminergic neuronal precursor cell (DANPC) therapy for Parkinson's disease. It operates in the United States.
Profile
- Company Name
- Aspen Neuroscience, Inc.
- Market
- NasdaqGS
- Founded
- Industry
- --
- Fiscal Year End
- --
- Website
- www.aspenneuroscience.com
Related Securities
Industry
Industry RankingsValueRank
Management
NamePosition
